-
1 Comment
Dian Diagnostics Group Co.,Ltd is currently in a long term downtrend where the price is trading 8.2% below its 200 day moving average.
From a valuation standpoint, the stock is 76.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.
Dian Diagnostics Group Co.,Ltd's total revenue rose by 35.4% to $3B since the same quarter in the previous year.
Its net income has increased by 283.5% to $398M since the same quarter in the previous year.
Finally, its free cash flow grew by 179.6% to $289M since the same quarter in the previous year.
Based on the above factors, Dian Diagnostics Group Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Diagnostics & Research |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE1000015N1 |
| Market Cap | 9B |
|---|---|
| PE Ratio | None |
| Dividend Yield | 5.1% |
| Target Price | 12.0129 |
| Beta | 0.68 |
Dian Diagnostics Group Co.,Ltd. operates as a third-party independent medical diagnostic service company in China. It offers medical diagnosis solutions for various general hospitals and specialty hospitals, community health service centers, township health centers, physical examination centers, disease prevention and control centers, and other medical and health institutions. It also engages in the research, development, and production of in vitro diagnostic reagents and related equipment. In addition, the company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions; multi-omics platform services; DP-TOF nucleic acid mass spectrometry solutions; and forensic drug testing products. Further, it provides supply chain optimization, information management, cold chain logistics, intelligent warehousing, sample library management, scientific research services, etc., as well as solutions for laboratory quality. The company was formerly known as Zhejiang DIAN Diagnostics Co., Ltd. and changed its name to Dian Diagnostics Group Co.,Ltd. in November 2017. Dian Diagnostics Group Co.,Ltd. was founded in 1996 and is based in Hangzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300244.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
